10th BIC 2019 is joining forces with the 3rd International Conference on Inhibitors for a memorable and exclusive scientific meeting
Mark the new date! Italy, 6-8 September 2019
Sign up now to the free e-mail alert service
Because Italy and Milan will be the site of the ISTH Congress in 2020 chaired by Flora Peyvandi, the Chairs of the Scientific Committee of the 10th BIC International Conference led again by Flora Peyvandi and Pier Mannuccio Mannucci have chosen to hold the 10th BIC in 2019 and combine it with another event focused specifically on factor VIII inhibitors.
We are therefore pleased to announce the Joint meeting of the 10th BIC and the 3rd Inhibitor Conference, which will be held in Italy from 6-8 September 2019.
Both conferences are recognized around the world as small meetings on very specialist topics presented by top speakers. A very exclusive event focusing on the most novel advances of basic science and clinical research in the field of hemophilia, rare inherited coagulation disorders, von Willebrand factor and von Willebrand disease and the thrombotic microangiopathies (TTP and HUS).
The Programme will not only include Scientific Sessions on the aforementioned topics by invited speakers but also freely submitted abstracts presented as oral communications or posters as well as Satellite Symposia sponsored by premier pharmaceutical companies. A new session of the Scientific Programme will focus on the best innovations by the industry in this field.
The tremendous innovations that have been presented at the most recent events suggest that 2019 will be a year of continuous development in treatment approaches and new drugs. Data from basic science research and clinical trials are sketching new scenarios not only in gene therapy but also in the progress of replacement and non-replacement therapies with new drugs appearing in the market.
At this Joint BIC & Inhibitors Conference, clinical and translational science will be discussed from all different angles during a 2 full-day programme. The most eminent experts in the field will present their very latest data and give their wise insight into the current science developments. Junior and less junior attendees will be able to submit their abstracts and have the chance to present them as oral communications or e-posters. Sponsor companies are invited to showcase their latest findings during their satellite symposia and discuss with a highly competent audience about further developments.
If you want to be kept informed about the detailed programme, location and start networking with the Joint BIC & Inhibitors Conference, please do sign up the free alert service in this page.
FREE E-MAIL ALERT SERVICE
JOINT BIC & INHIBITORS INTERNATIONAL CONFERENCE IS ORGANIZED BY
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
Former Director of the Hemophilia and Thrombosis Center of the Bari University Hospital. Coordinator of the Technical Panel on Thrombosis of the Apulia Region, Bari, Italy
Associate Professor of Hematology at the Department of Internal Medicine, University of Milan and Head of Hematology and Transfusion Medicine at the University Hospital L. Sacco of Milan, Italy
Department of Pathology and Molecular Medicine, Richardson Laboratory, Queen’s University, Kingston (ON), Canada
Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 1138, Centre de Recherche des Cordeliers Paris, France
Inserm U770, Le Kremlin-Bicêtre, France
Department of Plasma Proteins – Sanquin Research and University of Amsterdam, Amsterdam, the Netherlands